Journal of General Internal Medicine

, Volume 11, Issue 9, pp 554–556 | Cite as

Validity of self-report in identifying anabolic steroid use among weightlifters

  • Gary S. Ferenchick
Brief Reports

Abstract

To determine the validity of self-report in the detection of anabolic steroid use among weightlifters, self-report was compared with assay results of simultaneous urine samples from 48 male weightlifters. The sensitivity of self-report in the detection of urinary anabolic steroids was 74%, and specificity was 82%. In addition, 22 of 23 participants who declared current use had at least one undeclared anabolic steroid identified in their urine. However, 15 participants reported at least one drug that was not detected in the urine. Furthermore, 3 of 17 declared nonusers had objective evidence of steroids in their urine. The validity of self-report may be inadequate to differentiate reliably between users and nonusers.

Key words

anabolic steroids self-report validity weight-lifters drug abuse 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    DuRant RH, Rickert VI, Ashworth CS, Newman C, Slavens G. Use of multiple drugs among adolescents who use anabolic steroids. N Engl J Med. 1993;328:922–6.PubMedCrossRefGoogle Scholar
  2. 2.
    Yesalis CE, Kennedy NJ, Kopstein AN, Bahrke MS. Anabolic-androgenic steroid use in the United States. JAMA. 1993;270:1217–21.PubMedCrossRefGoogle Scholar
  3. 3.
    Anderson WA, Albrecht RR, McKeag DB. Second replication of a national survey of the substance use and abuse habits of college student athletes. Final report presented to National Collegiate Athletics Association, Overland Park, Kan, July 1993.Google Scholar
  4. 4.
    Haupt HA. Anabolic steroids and growth hormone. Am J Sports Med. 1993;21:468–73.PubMedGoogle Scholar
  5. 5.
    Lanas A, Sekar MC, Hirschowitz BI. Objective evidence of aspirin use in both ulcer and nonulcer upper and lower gastrointestinal bleeding. Gastroenterology. 1992;103:862–9.PubMedGoogle Scholar
  6. 6.
    Sherman MF, Bigelow GE. Validity of patients’ self-reported drug use as a function of treatment status. Drug Alcohol Depend. 1992;30:1–11.PubMedCrossRefGoogle Scholar
  7. 7.
    McNagny SE, Parker RM. High prevalence of recent cocaine use and the unreliability of patient self-report in an inner-city walk-in clinic. JAMA. 1991;267:1106–8.CrossRefGoogle Scholar
  8. 8.
    Ferenchick GS, Hirokawa S, Mammen EF, Schwartz KS. Anabolic-androgenic steroid abuse in weightlifters: evidence for activation of the hemostatic system. Am J Hematol. 1995;49:282–8.PubMedCrossRefGoogle Scholar
  9. 9.
    Narducci WA, Wagner JC, Hendrickson TP, Jeffrey TP. Anabolic steroids—a review of the clinical toxicology and diagnostic screening. Clin Toxicol. 1990;28:287–310.Google Scholar
  10. 10.
    Ansell JE, Tiarks C, Fairchild VK. Coagulation abnormalities associated with the use of anabolic steroids. Am Heart J. 1993;125:367–71.PubMedCrossRefGoogle Scholar
  11. 11.
    Bahrke MS, Wright JE, Strauss RH, Catlin DH. Psychological moods and subjectively perceived behavioral and somatic changes accompanying anabolic-androgenic steroid use. Am J Sports Med. 1992;20:717–24.PubMedGoogle Scholar
  12. 12.
    Cohen JC, Noakes TD, Benade AJS. Hypercholesterolemia in male power lifters using anabolic-androgenic steroids. Physician Sports-med. 1988;16:49–56.Google Scholar
  13. 13.
    DePiccoli B, Giada F, Benettin A, Sartori F, Piccolo E. Anabolic steroid use in body builders: an echocardiographic study of left ventricle morphology and function. Int J Sports Med. 1991;12:408–12.Google Scholar
  14. 14.
    Frohlich J, Kullmer T, Urhausen A, Bergmann R, Kindermann W. Lipid profile of body builders with and without self-administration of anabolic steroids. Eur J Appl Physiol. 1989;59:98–103.CrossRefGoogle Scholar
  15. 15.
    Hakkinen K, Alen M. Training volume, androgen use and serum creatine kinase activity. Br J Sports Med. 1989;23:188–9.PubMedGoogle Scholar
  16. 16.
    McKillop G, Ballantyne FC, Borland W, Dip CB, Ballantyne D. Acute metabolic effects of exercise in body builders using anabolic steroids. Br J Sports Med. 1989;23:186–7.PubMedGoogle Scholar
  17. 17.
    Moffatt RJ, Wallace MB, Sady SP. Effects of anabolic steroids on lipoprotein profiles of female weight lifters. Physician Sportsmed. 1990;18:106–15.Google Scholar
  18. 18.
    Moss HB, Panzak GL, Tarter RE. Sexual functioning of male anabolic steroid abusers. Arch Sex Behav. 1993;22:1–12.PubMedCrossRefGoogle Scholar
  19. 19.
    Urhausen A, Holpes R, Kindermann W. One- and two-dimensional echocardiography in bodybuilders using anabolic steroids. Eur J Appl Physiol. 1989;58:633–40.CrossRefGoogle Scholar
  20. 20.
    Zuliani U, Bernardini B, Catapano A, Campana M, Cerioli G, Spattini M. Effects of anabolic steroids, testosterone, and HGH on blood lipids and echocardiographic parameters in body builders. Int J Sports Med. 1988;10:62–6.CrossRefGoogle Scholar

Copyright information

© Blackwell Science, Inc. 1996

Authors and Affiliations

  • Gary S. Ferenchick
    • 1
  1. 1.B-314 Clinical CenterMichigan State UniversityEast Lansing

Personalised recommendations